Frontiers in immunology · 2025
Multi-omics analysis reveals neutrophil heterogeneity and key molecular drivers in sepsis-associated acute kidney injury.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cheng Tianle, Xu Yong, Liu Ziwei, Wang Yanchen, Zhang Ze, Huang Wenlin
Аннотация
Sepsis-associated acute kidney injury is a critical condition driven by immune dysregulation, particularly involving neutrophils, yet their heterogeneity and molecular contributions remain underexplored. This study employed a multi-omics approach, integrating single-cell and bulk RNA sequencing from 21 sepsis samples and Escherichia coli-induced sepsis datasets, alongside bioinformatics, machine learning, and experimental validation in a rat model and human peripheral blood. We identified four neutrophil subtypes-pro-inflammatory, anti-inflammatory, mature, and immature-revealing a significant increase in pro-inflammatory neutrophils in sepsis (40.53% versus 4.19% in controls) and a decrease in anti-inflammatory neutrophils (18.43% versus 27.04%). Four hub genes, peptidyl arginine deiminase 4, caspase 4, complement receptor 1, and mitogen-activated protein kinase 14, were pinpointed as key drivers, with peptidyl arginine deiminase 4 mediating neutrophil extracellular trap formation and exacerbating renal damage. In a rat model, peptidyl arginine deiminase 4 knockdown reduced trap formation and alleviated kidney injury (p-value less than 0.01). Human samples confirmed elevated gene expression in sepsis (p-value less than 0.05). These findings highlight neutrophil heterogeneity and molecular mechanisms in sepsis, with potential implications for sepsis-associated acute kidney injury (SAKI), proposing novel biomarkers and therapeutic targets for precision medicine.